News & Press Releases
BioFluidica to Exhibit at AACR National Meeting, San Diego, CA ~ April 5 – 10, 2024
April 5 - 10, 2024 This year Biofluidica will be exhibiting at AACR (booth #953). If you have any interest in exosomes as biomarkers this will be [Read More...]
BioFluidica Showcased Fetal Cell-Based DNA Test at #SMFM2024
February 11 - 14, 2024 BioFluidica, Inc. will be showcased their Fetal Cell-Based DNA Test (in development) at #SMFM2024 from Feb 11-14th! Visitors came to Booth #519 to [Read More...]
BioFluidica Exhibits at SITC, November 3 – 5
November 3 - 5, 2023 Biofluidica exhibited in San Diego November 1-5 at the Society for Immunotherapy of Cancer’s 39th Annual Meeting. Many researchers stopped the Biofluidica booth to [Read More...]
BioFluidica to Launch Prenatal Blood Screening Study
July 17, 2023 BioFluidica is currently seeking pregnant women aged 18 years and older in the early stages of pregnancy, specifically between 7-13 weeks for a prenatal [Read More...]
BioFluidica Exhibits at ASCO 2023
Chicago, IL, June 3-5, 2023 BioFluidica received a record number of visitors at Booth 27172 at the ASCO 2023 Annual Meeting at the McCormick Center in Chicago. [Read More...]
Assessing Breast Cancer Molecular Subtypes Using Extracellular Vesicles’ (EVs’) mRNA
Hu et al., Anal. Chem. 2023 May 16;95(19) 7665-7675 used LiquidScan to affinity capture EVs from plasma of breast cancer patients. Extracellular vesicles (EVs) carry RNA cargo that [Read More...]
BioFluidica Exhibits at AACR 2023, Orlando, FL
April 14-19, 2023 The BioFluidica booth at the recent American Association for Cancer Research, AACR, Annual Conference experienced much attention as scientists learned the potential of EV-subtype-based [Read More...]
HER2+ Breast Cancer Pilot Study
February 9, 2023 Blood was drawn from 16 breast cancer patients and enriched for Circulating Tumor Cells (CTCs) using LiquidScan. Isolated cells were analyzed for HER2 positivity [Read More...]
BioFluidica Exhibits and Presents at PMWC 2023 in Santa Clara, CA
February 9, 2023 BioFluidica attended the Precision Medicine World Conference (PMWC) 2023 on January 25-27th. Every year PMWC gathers top researchers and medical professionals from all over [Read More...]
Liquid Biopsies Take Center Stage at 2022 ASCO Annual Meeting
By Jamie Reno, June 15, 2022 BioFluidica presented its LiquidScan, a microfluidic chip that searches a blood sample for rare biomarkers such as CTCs (circulating tumor cells), cell-free [Read More...]
BioFluidica turns to blood for accurate, inexpensive cancer tests
San Diego Union Tribune | By Bradley J. Fikes, August 31, 2018 Blood is hard to beat for detecting disease. This liquid tissue circulates throughout the body, picking up [Read More...]